Title High fat-induced upregulation of LOX-1 expression in RF/6A cells with high glucose

Qin Li,Mingmei Zhang,Qianying Gao,Xueyi Chen
DOI: https://doi.org/10.21203/rs.3.rs-1989189/v1
2022-01-01
Abstract:Abstract AIM: To investigate the effect of oxidized low-density lipoprotein (ox-LDL) on the expression of lectin-like receptor of ox-LDL (LOX-1) and intercellular adhesion molecule-1 (ICAM-1) in the monkey choroid-retinal endothelial cell line RF/6A under high-glucose conditions. METHODS:RF/6A cells were grown in normal or high-glucose (25 mM) medium for 2 days. In parallel, RF/6A cells were grown in medium with high glucose and ox-LDL (25 or 50 μg/ml) or normal medium with ox-LDL (50 or 75 μg/ml), the concentrations of which were determined by initial screening based on migration and immunofluorescence. LOX-1 and ICAM-1 expression was determined by western blot analysis. The maximal effect on RF/6A cells was observed with a concentration of 25 mmol/l glucose and incubation for 48 h. Based on the immunofluorescence assay, the expression of LOX-1 was upregulated under high glucose compared with that under normal glucose and more pronounced with a glucose concentration of 50 μg/ml. Western blot indicated significant LOX-1 overexpression and blocked ICAM-1 activation under high-glucose conditions with or without ox-LDL in RF/6A cells.RESULTS: In the normal glucose+ox-LDL group (50 and 75 μg), LOX-1 expression increased as compared with that in the control group (P<0.01 and P<0.05, respectively). In the high glucose group (25 and 50 μg), expression of LOX-1 and ICAM-1 increased as compared with that in the control group (P>0.05 and P>0.01, respectively). CONCLUSION:These findings indicated that a certain concentration of ox-LDL blocks high-glucose-induced retinal vascular endothelial injury by inhibiting the upregulation of ICAM-1 expression due to a high-glucose environment. Thus, dyslipidemia may play an important role in the development of diabetic retinopathy, emphasizing the importance of active regulation of blood lipids in diabetic retinopathy therapy.
What problem does this paper attempt to address?